-
American Academy of Neurology Institute
The American Academy of Neurology Institute provided $150,000 to support the clinical research of Dana-Farber neurooncologist and palliative care specialist John Rhee, MD, MPH. The funds will help accelerate his work elevating care standards and developing therapeutic strategies that are better-tolerated than current options for glioma patients.
-
Lubins honored with Dana-Farber’s highest award for transformative impact
Richard and Nancy Lubin received the 2024 Sidney Farber Medical Research Award for their visionary philanthropy and unwavering commitment to cancer science and care.
-
Laurie H. Glimcher, MD, honored with endowed chair
A generous group of Trustees, colleagues, friends, and supporters contributed over $3 million to establish the chair and commemorate Glimcher’s legacy.
-
American Cancer Society enables pathbreaking new inquiries
Recent grants from the American Cancer Society fund innovative projects across Dana-Farber, from basic science to pediatric cancer disparities.
-
AACR targets breast and uterine cancers
The American Association for Cancer Research recently awarded more than $1 million in grants to Dana-Farber Cancer Institute investigators.
-
Cancer biologist Edward Chouchani receives Emerging Leader grant
The Mark Foundation grant advances groundbreaking research which revealed a substance long thought to be inert actually plays a key role in cell proliferation.
-
Faculty Research Fund sparks innovation
The Faculty Research Fund supports Dana-Farber priorities that transcend individual disciplines and facilitate breakthroughs across all cancer types.
-
Sheer joy and “finding the fun”: DFMC runners defy cancer with $8.8 million raised
Dana-Farber Marathon Challenge runners raised $8.8 million in 2024 to benefit the Claudia Adams Barr Program in Innovative Basic Cancer Research, advancing promising ideas at their earliest stages so they can move forward toward discovery and cure.
-
High-risk, high-reward research is The Mathers Foundation’s priority
Transformative basic research is the focus of The G. Harold and Leila Y. Mathers Charitable Foundation, which recently awarded $1.5 million to fund Dana-Farber research on unraveling the inner workings of human cells.
-
Grant fuels research into the new field of immunometabolism
With funding from the Chan Zuckerberg Initiative, Dana-Farber seeks to better understand and manipulate immunometabolism, which is emerging as an important frontier with potential to advance treatments for metabolic and inflammatory diseases including cancer.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.